Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Watchlist
Price: 15.12 EUR -1.18% Market Closed
Market Cap: 960.4m EUR

Eckert & Ziegler Strahlen und Medizintechnik AG
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Eckert & Ziegler Strahlen und Medizintechnik AG
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
Long-Term Debt
€37m
CAGR 3-Years
-4%
CAGR 5-Years
14%
CAGR 10-Years
20%
Carl Zeiss Meditec AG
XETRA:AFX
Long-Term Debt
€570.1m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stratec SE
XETRA:SBS
Long-Term Debt
€117m
CAGR 3-Years
12%
CAGR 5-Years
2%
CAGR 10-Years
41%
Siemens Healthineers AG
XETRA:SHL
Long-Term Debt
€11.3B
CAGR 3-Years
-6%
CAGR 5-Years
105%
CAGR 10-Years
N/A
Draegerwerk AG & Co KGaA
XETRA:DRW8
Long-Term Debt
€153.9m
CAGR 3-Years
-5%
CAGR 5-Years
28%
CAGR 10-Years
-3%
Sartorius AG
XETRA:SRT
Long-Term Debt
€3.4B
CAGR 3-Years
27%
CAGR 5-Years
11%
CAGR 10-Years
25%
No Stocks Found

Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View

Market Cap
946.1m EUR
Industry
Health Care

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

EUZ Intrinsic Value
20.27 EUR
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Long-Term Debt?
Long-Term Debt
37m EUR

Based on the financial report for Sep 30, 2025, Eckert & Ziegler Strahlen und Medizintechnik AG's Long-Term Debt amounts to 37m EUR.

What is Eckert & Ziegler Strahlen und Medizintechnik AG's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
20%

Over the last year, the Long-Term Debt growth was -13%. The average annual Long-Term Debt growth rates for Eckert & Ziegler Strahlen und Medizintechnik AG have been -4% over the past three years , 14% over the past five years , and 20% over the past ten years .

Back to Top